The global drug eluting stent market was valued at USD 5.89 Billion in 2019 and is expected to reach USD 9.10 Billion by year 2026, with a CAGR of 5.75 % during forecast period 2020 to 2027.
The study covers in-depth analysis of drug eluting stents and its extensive use in the cardiovascular diseases. Drug eluting stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Drug eluting stents are usually preferred over bare metal stents for most people. Drug eluting stents are generally to keep the blockage from recurring compared to bare metal stents. One of the major objectives of drug eluting stents is to limit neointimal hyperplasia. The global drug eluting stent market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries.
Key growth indicators of the drug-eluting stents market, including historical value and volume analysis, pricing analysis, value and supply chain analysis, and Y-o-Y growth trend analysis have been elucidated in the report. Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.
VRR covers a detailed taxonomy of the drug-eluting stents market, along with an incisive outlook on the competitive scenario. The report profiles a list of companies operating in the drug-eluting stents market, wherein, the product portfolios, technological innovations, geographical expansion, and key growth strategies of these players have been mentioned in detail.
The report on the drug-eluting stents market allows stakeholders to understand key demand trends that end users may seek in the long run, and the appropriate sourcing strategy for the same. For companies involved in the drug-eluting stents market, the report helps understand key end users contributing to demand, allowing them to strategically formulate steps to enhance their sales prospects.
Key players in the global drug eluting market include Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation
Key Segments
Segmentation:
Drug-eluting stents Market by Product
Drug-eluting stents Market by Drug
Drug-eluting stents Market by Generation
Drug-eluting stents Market by Scaffold
Drug-eluting stents Market by Application
Drug-eluting stents Market by Region
Research Methodology
The drug-eluting stents market report is a result of unique research methodology, which includes a perfect combination of primary research, secondary research, and expert panel reviews. The data repository for the drug-eluting stents market is updated on a continuous basis, with key stakeholders and their developments tracked at regular intervals.
Secondary sources such as annual reports, company websites, industry white papers, government publications, investor presentations, statistical databases, internal and external proprietary databases, and regulatory databases are generally referred to for developing preliminary market understanding.
Primary research involves interviews and e-mail interactions with C-level executives, KOLs, and regional officers of companies operating in the drug eluting stents market, for unbiased, yet detailed reviews on the drug-eluting stents market across different geographical divisions.
Information obtained from secondary resources and verified by primary resources have contributed to the compilation of the drug-eluting stents market report.
Section 1. Synopsis
1.1. Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Section 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Section 3. Indicative Metrics
3.1. Rising prevalence of cardiovascular diseases
3.2. Growing acceptance for minimally invasive endovascular surgeries
3.3. Rise in the geriatric population
Section 4. Drug Eluting Stents Segmentation & Impact Analysis
4.1. Drug Eluting Stents Segmentation Analysis
4.2. Drug Eluting Stents Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Drug Eluting Stents Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Rise in public health awareness
4.4.1.2. Supportive regulatory environment for drug eluting products
4.4.2. Market restraint analysis
4.4.2.1. Strict regulatory approval process
4.4.2.2. Lack of skilled professionals
4.5. Key opportunities prioritized
4.6. Drug Eluting Stents Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Drug Eluting Stents PESTEL Analysis
Section 5. Drug Eluting Stents Market By Coating Type Insights & Trends
5.1. Drug Eluting Stents Type dynamics & Market Share, 2018 & 2026
5.2. Polymer based coating
5.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
5.3. Polymer free coating
5.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 6. Drug Eluting Stents Market By Application Type Insights & Trends
6.1. Drug Eluting Stents Disease Type dynamics & Market Share, 2018 & 2026
6.2. Coronary Artery Disease
6.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
6.2.3. Peripheral Artery Disease
6.2.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
6.2.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 7. Drug Eluting Stents Market By End Use Insights & Trends
7.1. Drug Eluting Stents End Use dynamics & Market Share, 2018 & 2026
7.2. Hospital
7.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
7.3. Cardiology Centers
7.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
7.4. Ambulatory Surgical Centers
7.4.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 8. Drug Eluting Stents Market Regional Outlook
8.1. Drug Eluting Stents Market share by region, 2018 & 2026
8.2. North America
8.2.1. North America Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.2. North America Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.3. North America Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.4. North America Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.2.5. U.S.
8.2.5.1. U.S. Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.5.2. U.S. Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.5.3. U.S. Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.5.4. U.S. Drug Eluting Stents Market estimates and forecast by End use, 2016 – 2026, (USD Million)
8.2.6. Canada
8.2.6.1. Canada Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.6.2. Canada Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.6.3. Canada Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.6.4. Canada Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3. Europe
8.3.1. Europe Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.2. Europe Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.3. Europe Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.4. Europe Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.5. Germany
8.3.5.1. Germany Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.5.2. Germany Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.5.3. Germany Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.5.4. Germany Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.6. France
8.3.6.1. France Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.6.2. France Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.6.3. France Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.6.4. France Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.7. U.K.
8.3.7.1. U.K Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.7.2. U.K Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.7.3. U.K. Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.7.4. U.K. Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.8. Spain
8.3.8.1. Spain Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.8.2. Spain Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.8.3. Spain. Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.8.4. Spain Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.9. Italy
8.3.9.1. Italy Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.9.2. Italy Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.9.3. Italy Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.9.4. Italy Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.10.2. Rest of Europe Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.10.3. Rest of Europe Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.10.4. Rest of Europe Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.2. Asia Pacific Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.3. Asia Pacific Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.4. Asia Pacific Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.5. China
8.4.5.1. China Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.5.2. China Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.5.3. China Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.5.4. China Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.6. Japan
8.4.6.1. Japan Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.6.2. Japan Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.6.3. Japan Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.6.4. Japan Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.7. India
8.4.7.1. India Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.7.2. India Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.7.3. India Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.7.4. India Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.8.2. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.8.3. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.8.4. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.5. Middle East & Africa
8.5.1. Middle East and Africa Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.5.2. Middle East and Africa Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.5.3. Middle East and Africa Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.5.4. Middle East and Africa Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.6. Latin America
8.6.1. Latin America Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.6.2. Latin America Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.6.3. Latin America Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.6.4. Latin America Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.6.5. Brazil
8.6.5.1. Brazil Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.6.5.2. Brazil Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.6.5.3. Brazil Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.6.5.4. Brazil Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
Section 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Strategy Benchmarking
9.5. Vendor Landscape
Section 10. Company Profiles
10.1. Terumo Corporation
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Length Benchmarking
10.1.4. Strategic Initiatives
10.2. Biosensors
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Length Benchmarking
10.2.4. Strategic Initiatives
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Length Benchmarking
10.3.4. Strategic Initiatives
10.4. Boston Scientific Corporation
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Length Benchmarking
10.4.4. Strategic Initiatives
10.5. Medtronic PLC
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Length Benchmarking
10.5.4. Strategic Initiatives
10.6. Biotronik SE & Co. KG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Length Benchmarking
10.6.4. Strategic Initiatives
10.7. MicroPort Scientific Corporation
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Length Benchmarking
10.7.4. Strategic Initiatives
10.7.5. Strategic Initiatives